275 related articles for article (PubMed ID: 21417262)
1. Improving VEGFR-2 docking-based screening by pharmacophore postfiltering and similarity search postprocessing.
Planesas JM; Claramunt RM; Teixidó J; Borrell JI; Pérez-Nueno VI
J Chem Inf Model; 2011 Apr; 51(4):777-87. PubMed ID: 21417262
[TBL] [Abstract][Full Text] [Related]
2. Investigation of MM-PBSA rescoring of docking poses.
Thompson DC; Humblet C; Joseph-McCarthy D
J Chem Inf Model; 2008 May; 48(5):1081-91. PubMed ID: 18465849
[TBL] [Abstract][Full Text] [Related]
3. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
Deng Z; Chuaqui C; Singh J
J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
[TBL] [Abstract][Full Text] [Related]
4. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
Perola E; Walters WP; Charifson PS
Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
[TBL] [Abstract][Full Text] [Related]
5. Scoring ligand similarity in structure-based virtual screening.
Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.
Yu H; Wang Z; Zhang L; Zhang J; Huang Q
Bioorg Med Chem Lett; 2007 Apr; 17(8):2126-33. PubMed ID: 17306530
[TBL] [Abstract][Full Text] [Related]
7. New scoring functions for virtual screening from molecular dynamics simulations with a quantum-refined force-field (QRFF-MD). Application to cyclin-dependent kinase 2.
Ferrara P; Curioni A; Vangrevelinghe E; Meyer T; Mordasini T; Andreoni W; Acklin P; Jacoby E
J Chem Inf Model; 2006; 46(1):254-63. PubMed ID: 16426061
[TBL] [Abstract][Full Text] [Related]
8. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
[TBL] [Abstract][Full Text] [Related]
9. Rescoring ligand docking poses.
Zhong S; Zhang Y; Xiu Z
Curr Opin Drug Discov Devel; 2010 May; 13(3):326-34. PubMed ID: 20443166
[TBL] [Abstract][Full Text] [Related]
10. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.
Renner S; Schneider G
J Med Chem; 2004 Sep; 47(19):4653-64. PubMed ID: 15341481
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening and synthesis of new chemical scaffolds as VEGFR-2 kinase inhibitors.
Elsayed MS; El-Araby ME; Serya RT; Abouzid KA
Arzneimittelforschung; 2012 Dec; 62(12):554-60. PubMed ID: 23023518
[TBL] [Abstract][Full Text] [Related]
12. Integrating structure- and ligand-based virtual screening: comparison of individual, parallel, and fused molecular docking and similarity search calculations on multiple targets.
Tan L; Geppert H; Sisay MT; Gütschow M; Bajorath J
ChemMedChem; 2008 Oct; 3(10):1566-71. PubMed ID: 18651695
[TBL] [Abstract][Full Text] [Related]
13. Novel method for generating structure-based pharmacophores using energetic analysis.
Salam NK; Nuti R; Sherman W
J Chem Inf Model; 2009 Oct; 49(10):2356-68. PubMed ID: 19761201
[TBL] [Abstract][Full Text] [Related]
14. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
[TBL] [Abstract][Full Text] [Related]
15. Combining machine learning and pharmacophore-based interaction fingerprint for in silico screening.
Sato T; Honma T; Yokoyama S
J Chem Inf Model; 2010 Jan; 50(1):170-85. PubMed ID: 20038188
[TBL] [Abstract][Full Text] [Related]
16. An integrated virtual screening approach for VEGFR-2 inhibitors.
Zhang Y; Yang S; Jiao Y; Liu H; Yuan H; Lu S; Ran T; Yao S; Ke Z; Xu J; Xiong X; Chen Y; Lu T
J Chem Inf Model; 2013 Dec; 53(12):3163-77. PubMed ID: 24266594
[TBL] [Abstract][Full Text] [Related]
17. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy.
Cross JB; Thompson DC; Rai BK; Baber JC; Fan KY; Hu Y; Humblet C
J Chem Inf Model; 2009 Jun; 49(6):1455-74. PubMed ID: 19476350
[TBL] [Abstract][Full Text] [Related]
18. Prediction of multiple binding modes of the CDK2 inhibitors, anilinopyrazoles, using the automated docking programs GOLD, FlexX, and LigandFit: an evaluation of performance.
Sato H; Shewchuk LM; Tang J
J Chem Inf Model; 2006; 46(6):2552-62. PubMed ID: 17125195
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of library ranking efficacy in virtual screening.
Kontoyianni M; Sokol GS; McClellan LM
J Comput Chem; 2005 Jan; 26(1):11-22. PubMed ID: 15526325
[TBL] [Abstract][Full Text] [Related]
20. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
